Chemical Compound

Ibrexafungerp citrate

CAS Registry Number 1965291-08-0
Back to search Request a Quote
Ibrexafungerp citrate chemical structure
Primary Record

Ibrexafungerp citrate

In stock
7,984 g
Purity
98.1 %
CAS
1965291-08-0

Compound Identifiers & Properties

CAS
1965291-08-0
PubChem CID
137552087
SMILES
C[C@H](C(C)C)[C@]1(CC[C@@]2([C@H]3CC[C@H]4[C@]5(COC[C@]4(C3=CC[C@]2([C@@H]1C(=O)O)C)C[C@H]([C@@H]5OC[C@@](C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
Canonical SMILES
CC(C)[C@@H](C)[C@@]1(C)CC[C@]2(C)[C@H]3CC[C@@H]4[C@@]5(COC[C@@]4(C)[C@@H](OC[C@](C)(N)C(C)(C)C)[C@H](n4ncnc4-c4ccncc4)C5)C3=CC[C@@]2(C)[C@@H]1C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O

Names & Synonyms

  • Ibrexafungerp citrate
  • brexafemme
  • SCY-078 citrate
  • Brexafemme Citrate
  • Brexafemme (TN)
  • M4NU2SDX3E
  • UNII-M4NU2SDX3E
  • Ibrexafungerp (citrate)
  • Ibrexafungerp citrate?
  • Ibrexafungerp citrate [USAN]
  • RefChem:56933
  • 1965291-08-0
  • Ibrexafungerp citrate (USAN)
  • orb1739451
  • CHEMBL4298168
  • SCHEMBL29404341
  • EX-A7291A
  • GLXC-26020
  • BBF-05812
  • IBREXAFUNGERP CITRATE [WHO-DD]
  • HY-107126A
  • IBREXAFUNGERP CITRATE [ORANGE BOOK]
  • CS-0146666
  • D11545
  • G91326
  • 4H-1,4a-Propano-2H-phenanthro(1,2-C)pyran-7-carboxylic acid, 15-((2R)-2-amino-2,3,3-trimethylbutoxy)-8-((1R)-1,2-dimethylpropyl)-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-(5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl)-, (1S,4aR,6as
  • 4H-1,4A-PROPANO-2H-PHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID, 15-((2R)-2-AMINO-2,3,3-TRIMETHYLBUTOXY)-8-((1R)-1,2-DIMETHYLPROPYL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-1,6A,8,10A-TETRAMETHYL-14-(5-(4-PYRIDINYL)-1H-1,2,4-TRIAZOL-1-YL)-, (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
  • (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid
  • (1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-2-((R)-2-amino-2,3,3-trimethylbutoxy)-1,6a,8,10a-tetramethyl-8-((R)-3-methylbutan-2-yl)-3-(5-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid--2-hydroxypropane-1,2,3-tricarboxylic acid (1/1)
  • (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-15-((2R)- 2-AMINO-2,3,3-TRIMETHYLBUTOXY)-1,6A,8,10A-TETRAMETHYL-8- ((2R)-3-METHYLBUTAN-2-YL)-14-(5-(PYRIDIN-4-YL)-1H-1,2,4- TRIAZOL-1-YL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-2H,4H-1,4A-PROPANOPHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID COMPOUND WITH 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID (1:1)
  • (1S,4AR,6AS,7R,8R,10AR,10BR,12AR,14R,15R)-15-((2R)-2-AMINO-2,3,3-TRIMETHYLBUTOXY)-1,6A,8,10A-TETRAMETHYL-8-((2R)-3-METHYLBUTAN-2-YL)-14-(5-(PYRIDIN-4-YL)-1H-1,2,4-TRIAZOL-1-YL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DODECAHYDRO-2H,4H-1,4A-PROPANOPHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID COMPOUND WITH 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLIC ACID (1:1)
  • (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-15-[(2R)- 2-amino-2,3,3-trimethylbutoxy]-1,6a,8,10a-tetramethyl-8- [(2R)-3-methylbutan-2-yl]-14-[5-(pyridin-4-yl)-1H-1,2,4- triazol-1-yl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-2H,4H-1,4a-propanophenanthro[1,2-c]pyran-7-carboxylic acid compound with 2-hydroxypropane-1,2,3-tricarboxylic acid